A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP)

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

October 24, 2030

Study Completion Date

October 24, 2030

Conditions

X-Linked Retinitis Pigmentosa

Interventions

BIOLOGICAL

AAV5-hRKp.RPGR

AAV5-hRKp.RPGR will be administered sub-retinally.

OTHER

No intervention (Follow-Up assessment)

Participants will not receive any intervention and will undergo follow-up assessment.

Trial Locations (3)

RECRUITING

University of Michigan Kellogg Eye Center, Ann Arbor

RECRUITING

Massachusetts Eye and Ear Infirmary, Boston

RECRUITING

Moorfields Eye Hospital, London

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY